Clinical Trial Update: Trident II Revision Outcomes Study [NA]

View source ↗

Summary

A terminated hip revision arthroplasty trial (Trident II Revision Outcomes Study) with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Arthroplasty
• Hip Joint Disease

Drugs mentioned

• Trident II Revision (Stryker Orthopaedics)

Snippet

Sponsor: Stryker Orthopaedics | Conditions: Arthroplasty, Hip Revision | NA | Status: TERMINATED | Results posted: 2023-12-01